GlaxoSmithKline reshapes Consumer Healthcare
3 May 2013
GlaxoSmithKline’s decision to divest its Lucozade and Ribena drinks is another step in the company’s strategy of transforming its consumer unit into the world’s “first and best fast-moving consumer healthcare” operation.
